RAPT vs DNTH โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
DNTH Captures Institutional Edge (2โ1 Pillars ยท 3โ4 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Dianthus Therapeutics, Inc. Common Stock (DNTH) driven by superior Growth & Margin, Options & Structure while RAPT counters with relative strength in Momentum & Technical. Fundamentally, RAPT trades at N/M Forward P/E with 0.0% operating margin (-100.0% YoY revenue) versus DNTH at N/M Forward P/E and -8683.9% operating margin (+205.6% YoY). In options structure, RAPT sits in UNCLASSIFIED (<1st %ile IV; Dealer Gamma Walls on Pro) against DNTH sits in CONSOLIDATION (7th %ile IV; Dealer Gamma Walls on Pro).
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | RAPT | DNTH | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $1.7B | $5.2B | Larger Scale | DNTH |
| Trailing P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Forward P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Revenue Growth (YoY) Growth | -100.0% | +205.6% | Higher Growth | DNTH |
| Operating Margin (TTM) Profitability | 0.0% | -8683.9% | Higher Margin | RAPT |
| Net Profit Margin Profitability | 0.0% | 0.0% | Higher Margin | Tie |
| Return on Equity (ROE) Capital Efficiency | -85.4% | -22.6% | Higher ROE | DNTH |
| 52-Week Range Position Momentum | 100% ($1โ$58) | 65% ($34โ$118) | Stronger Trend | RAPT |
| Beta / 30D Volatility Risk Regime | -0.02ฮฒ ยท 2% Vol | 1.04ฮฒ ยท 41% Vol | Lower Realized Risk | RAPT |
| Unified Institutional Score Composite Signal | 52.4 / 100 (HOLD) | 34.1 / 100 (SELL) | Higher Composite | RAPT |